Invasight

About:

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

Top Investors: HTGF | High-Tech Gruenderfonds, Verve Ventures, Venture Kick, Zürcher Kantonal Bank, Wille Finance

Description:

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

Total Funding Amount:

4.59M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Zürich, Zurich, Switzerland

Founded Date:

2019-01-01

Contact Email:

info(AT)invasight.com

Founders:

James Smith, Karthiga Kumar

Number of Employees:

1-10

Last Funding Date:

2022-06-06

IPO Status:

Private

Industries: